McKesson Europe Competitors

1933 Industries (OTCMKTS:TGIFF) and McKesson Europe (OTCMKTS:CAKFY) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a summary of recent recommendations for 1933 Industries and McKesson Europe, as provided by MarketBeat.com.

Profitability

This table compares 1933 Industries and McKesson Europe's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares 1933 Industries and McKesson Europe's revenue, earnings per share and valuation.

4Front Ventures (OTCMKTS:FFNTF) and McKesson Europe (OTCMKTS:CAKFY) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a summary of recent recommendations for 4Front Ventures and McKesson Europe, as provided by MarketBeat.com.

Profitability

This table compares 4Front Ventures and McKesson Europe's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares 4Front Ventures and McKesson Europe's revenue, earnings per share and valuation.

AB Science (OTCMKTS:ABSCF) and McKesson Europe (OTCMKTS:CAKFY) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a summary of recent recommendations for AB Science and McKesson Europe, as provided by MarketBeat.com.

Profitability

This table compares AB Science and McKesson Europe's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares AB Science and McKesson Europe's revenue, earnings per share and valuation.

Summary

AB Science beats McKesson Europe on 1 of the 1 factors compared between the two stocks.

McKesson Europe (OTCMKTS:CAKFY) and Abacus Health Products (OTCMKTS:ABAHF) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for McKesson Europe and Abacus Health Products, as reported by MarketBeat.

Profitability

This table compares McKesson Europe and Abacus Health Products' net margins, return on equity and return on assets.

Valuation & Earnings

This table compares McKesson Europe and Abacus Health Products' top-line revenue, earnings per share (EPS) and valuation.

McKesson Europe (OTCMKTS:CAKFY) and Abattis Bioceuticals (OTCMKTS:ATTBF) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

Profitability

This table compares McKesson Europe and Abattis Bioceuticals' net margins, return on equity and return on assets.

Earnings and Valuation

This table compares McKesson Europe and Abattis Bioceuticals' top-line revenue, earnings per share (EPS) and valuation.

Analyst Ratings

This is a breakdown of current ratings and target prices for McKesson Europe and Abattis Bioceuticals, as reported by MarketBeat.com.

McKesson Europe (OTCMKTS:CAKFY) and Acreage (OTCMKTS:ACRDF) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

Profitability

This table compares McKesson Europe and Acreage's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares McKesson Europe and Acreage's top-line revenue, earnings per share (EPS) and valuation.

Analyst Ratings

This is a breakdown of current ratings and target prices for McKesson Europe and Acreage, as reported by MarketBeat.com.

Acreage has a consensus price target of $6.00, suggesting a potential upside of 131.53%. Given Acreage's higher possible upside, analysts clearly believe Acreage is more favorable than McKesson Europe.

Summary

Acreage beats McKesson Europe on 2 of the 2 factors compared between the two stocks.